Yurtec Corporation
Yurtec Corporation (1934.T) Financial Performance & Income Statement Overview
Analyze Yurtec Corporation (1934.T) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Yurtec Corporation (1934.T) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Yurtec Corporation 1934.T financial performance.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $75.41B | $70.75B | $62.05B | $48.99B |
| Cost of Revenue | $62.002B | $59.11B | $53.45B | $43.09B |
| Gross Profit | $13.41B | $11.64B | $8.60B | $5.91B |
| Gross Profit Ratio | $0.18 | $0.16 | $0.14 | $0.12 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $6.81B | $5.57B | $5.58B | $5.41B |
| Operating Expenses | $6.81B | $5.57B | $5.58B | $5.41B |
| Total Costs & Expenses | $68.82B | $64.67B | $59.03B | $48.49B |
| Interest Income | $135.00M | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $1.26B | $1.22B | $1.21B | $1.22B |
| EBITDA | $8.35B | $7.30B | $4.25B | $1.72B |
| EBITDA Ratio | $0.11 | $0.10 | $0.07 | $0.04 |
| Operating Income | $6.59B | $6.08B | $3.02B | $499.00M |
| Operating Income Ratio | $0.09 | $0.09 | $0.05 | $0.01 |
| Other Income/Expenses (Net) | $477.00M | -$229.00M | $230.00M | $597.00M |
| Income Before Tax | $7.07B | $5.85B | $3.25B | $1.10B |
| Income Before Tax Ratio | $0.09 | $0.08 | $0.05 | $0.02 |
| Income Tax Expense | $1.89B | $1.94B | $910.00M | $526.00M |
| Net Income | $5.18B | $3.90B | $2.34B | $569.00M |
| Net Income Ratio | $0.07 | $0.06 | $0.04 | $0.01 |
| EPS | $74.14 | $55.84 | $32.59 | $7.94 |
| Diluted EPS | $74.14 | $55.84 | $32.59 | $7.94 |
| Weighted Avg Shares Outstanding | $69.81M | $69.87M | $71.68M | $71.66M |
| Weighted Avg Shares Outstanding (Diluted) | $69.81M | $69.87M | $71.68M | $71.66M |
Financial performance has remained strong, with revenue growing from $48.99B in Q1 2024 to $75.41B in Q4 2024. Gross profit continued to perform well, with margins at 18% in the latest quarter. Operating income reached $6.59B in Q4 2024, holding a steady 9% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $8.35B. Net income rose to $5.18B, keeping EPS at $74.14. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan